NCT00971763View on ClinicalTrials.gov

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

cyclophosphamide

DRUG

gemcitabine hydrochloride

DRUG

prednisolone

DRUG

vincristine sulfate

Trial Locations (4)

BN2 5BE

Sussex Cancer Centre at Royal Sussex County Hospital, Brighton

LS1 3EX

Leeds General Infirmary, Leeds

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

SE1 9RT

Cancer Research UK and University College London Cancer Trials Centre, London

All Listed Sponsors
lead

University College, London

OTHER

NCT00971763 - Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | Biotech Hunter | Biotech Hunter